A few practical tips to consider when navigating insurance coverage and prior authorizations
You may have noticed that conversations around GLP-1 have been popping up everywhere lately
However, patients with type 2 diabetes were included in these trials [52, 53], which could have contributed to the observed differences
Bimagrumab is a monoclonal antibody that binds to both ActRIIA and ActRIIB, preventing myostatin and activin A from activating these receptors
This is a universal principle in pharmacology: combination therapy with lower individual doses often produces better outcomes with fewer adverse effects than high-dose monotherapy
Hou H, Qiu Y, Zhang J, Hu Y, Su S, Wang Y